» Authors » Keigo Machida

Keigo Machida

Explore the profile of Keigo Machida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 87
Citations 3105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez J, Chen C, Machida T, Uthaya Kumar D, Tahara S, Montana J, et al.
iScience . 2025 Mar; 28(3):112032. PMID: 40060897
[This retracts the article DOI: 10.1016/j.isci.2023.106254.].
2.
Yeh D, Liu C, Hernandez J, Tahara S, Tsukamoto H, Machida K
iScience . 2024 Dec; 27(12):111489. PMID: 39717084
[This retracts the article DOI: 10.1016/j.isci.2023.107035.].
3.
4.
Chen C, Tsukamoto H, Liu J, Kashiwabara C, Feldman D, Sher L, et al.
J Clin Invest . 2024 Oct; 134(19). PMID: 39352392
No abstract available.
5.
Choi H, Zhu Y, Zhao X, Mehta S, Hernandez J, Lee J, et al.
Exp Mol Med . 2024 Feb; 56(2):461-477. PMID: 38409448
The P53-destabilizing TBC1D15-NOTCH protein interaction promotes self-renewal of tumor-initiating stem-like cells (TICs); however, the mechanisms governing the regulation of this pathway have not been fully elucidated. Here, we show that...
6.
Zhu Y, Tahara S, Tsukamoto H, Machida K
STAR Protoc . 2023 Dec; 4(4):102389. PMID: 38103196
We detail procedures for generating a humanized mouse model of hepatocellular carcinoma (HCC) recapitulating genetic mutations associated with metabolic liver diseases (MLD). We humanized liver parenchymal, non-parenchymal, and hematopoietic cells....
7.
Nakagawa C, Kadlera Nagaraj M, Hernandez J, Uthay Kumar D, Shukla V, Machida R, et al.
Front Immunol . 2023 Sep; 14:1204907. PMID: 37744383
Introduction: Tumor-initiating cells (TICs) are rare, stem-like, and highly malignant. Although intravenous hepatitis B and C immunoglobulins have been used for HBV and HCV neutralization in patients, their tumor-inhibitory effects...
8.
Yeh D, Liu C, Hernandez J, Tahara S, Tsukamoto H, Machida K
iScience . 2023 Jul; 26(7):107035. PMID: 37448562
The synergistic effect of alcohol and HCV mediated through TLR4 signaling transactivates NANOG, a pluripotency transcription factor important for the stemness of tumor-initiating stem-like cells (TICs). NANOG together with the...
9.
Ha D, Shin W, Hernandez J, Neamati N, Dubeau L, Machida K, et al.
Viruses . 2023 May; 15(5). PMID: 37243204
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, has given rise to many new variants with increased transmissibility and the ability to evade...
10.
Sinha S, Aizawa S, Nakano Y, Rialdi A, Choi H, Shrestha R, et al.
Nat Commun . 2023 May; 14(1):2651. PMID: 37156770
Hepatocellular carcinoma (HCC) is the 3 most deadly malignancy. Activated hepatic stellate cells (aHSC) give rise to cancer-associated fibroblasts in HCC and are considered a potential therapeutic target. Here we...